Alvarado, Michael D.
University of California, San Francisco
3 papers on CoChatORCID 0009-0003-7309-567X
Most cited papers
- Verified
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
Barry, K. C., Hsu, J., Broz, M. L., Cueto, F. J., Binnewies, M., Combes, A. J., Nelson, A. E., Loo, K., Kumar, R., Rosenblum, M. D., et al. (2018) · Nature Medicine
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,021
- Verified
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
Vaidya, J. S., Joseph, D. J., Tobias, J. S., Bulsara, M., Wenz, F., Saunders, C., Alvarado, M., Flyger, H. L., Massarut, S., Eiermann, W., et al. (2010) · The Lancet
Breast Cancer Treatment StudiesAdvanced Radiotherapy Techniques
Cited by 772
- Verified
Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
Daud, A. I., Loo, K., Pauli, M. L., Sanchez-Rodriguez, R., Sandoval, P. M., Taravati, K., Tsai, K., Nosrati, A., Nardo, L., Alvarado, M. D., et al. (2016) · Journal of Clinical Investigation
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 525
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free